Noninvasive Prenatal Diagnostics Market Share Driven by Rising Demand for Early Genetic Screening and Safer Pregnancy Testing | Valuates Reports

Noninvasive Prenatal Diagnostics Market Size
The global market for Noninvasive Prenatal Diagnostics was valued at US$ 10540 million in the year 2024 and is projected to reach a revised size of US$ 23780 million by 2031, growing at a CAGR of 12.5% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-34G2124/Global_Noninvasive_Prenatal_Diagnostics_Market_Insights_and_Forecast_to_2028

The Noninvasive Prenatal Diagnostics (NIPD) Market is experiencing rapid growth due to increasing awareness of early genetic screening, advancements in molecular diagnostics, and the growing preference for safer, noninvasive testing methods during pregnancy. NIPD techniques analyze fetal DNA circulating in the maternal bloodstream to detect chromosomal abnormalities and genetic conditions without the risks associated with invasive procedures such as amniocentesis. As healthcare systems emphasize early diagnosis and preventive care, the global NIPD market is expected to expand significantly over the forecast period.

Based on type segmentation, the market includes services and instruments. NIPD services account for a major share of the market, as most prenatal tests are conducted through specialized laboratories offering genetic screening services to hospitals and clinics. These services include screening for conditions such as Down syndrome, trisomy 18, and other chromosomal abnormalities. NIPD instruments, including sequencing platforms and diagnostic equipment, are used by laboratories and healthcare providers to conduct in-house testing and research, supporting the expansion of molecular diagnostic capabilities.

In terms of application, hospitals represent the largest segment of the NIPD market, as they are primary centers for prenatal care and diagnostic testing. Hospitals collaborate with diagnostic laboratories to provide accurate and timely genetic screening for pregnant women. The personal segment is also growing, driven by increasing consumer awareness and demand for direct-to-consumer genetic testing services. Other applications include specialized diagnostic centers and research institutions involved in prenatal genetic studies and clinical trials.

Several biotechnology and diagnostics companies are actively operating in the noninvasive prenatal diagnostics market. Key players include Natera, Illumina, BGI Genomics, and Ariosa Diagnostics. Other notable companies include Quest Diagnostics, Premaitha Health, NIPD Genetics, Labcorp, Ravgen, LifeCodexx, Trovagene, and Berry Genomics. These companies are focusing on improving test accuracy, expanding test panels, and leveraging next-generation sequencing technologies to enhance prenatal diagnostic capabilities.

From a regional perspective, North America dominates the noninvasive prenatal diagnostics market due to advanced healthcare infrastructure, high adoption of genetic testing technologies, and strong presence of leading diagnostic companies. Europe also holds a significant share, supported by increasing awareness of prenatal screening and favorable healthcare policies. Meanwhile, the Asia-Pacific region is expected to witness rapid growth due to rising healthcare investments, increasing birth rates, and growing awareness of genetic testing in countries such as China, Japan, South Korea, and India. Emerging markets in Latin America and the Middle East & Africa are also gradually adopting noninvasive prenatal diagnostic technologies, further contributing to the growth of the global NIPD market.

Segment by Type

• Services
• Instrument

Segment by Application

• Hospital
• Personal
• Other

By Company

Natera, Illumina, BGI Diagnosis, Ariosa Diagnostics, Quest Diagnostics, Premaitha Health, NIPD Genetics, Labcorp, Ravgen, LifeCodexx, TrovaGene, Berry Genomics

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-34G2124/global-noninvasive-prenatal-diagnostics

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.